Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lecanemab: First Approval
Sheridan M. Hoy
Drugs (2023) Vol. 83, Iss. 4, pp. 359-365
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Antibodies to watch in 2024
Silvia Crescioli, Hélène Kaplon, Alicia M. Chenoweth, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 83
Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs
Samridhi Thakral, Alka Yadav, Vikramjeet Singh, et al.
Ageing Research Reviews (2023) Vol. 88, pp. 101960-101960
Closed Access | Times Cited: 51
Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment
James Naude, Meng Wang, Rebeca Leon, et al.
Neurobiology of Aging (2024) Vol. 138, pp. 19-27
Open Access | Times Cited: 16
Alzheimer’s disease and drug delivery across the blood–brain barrier: approaches and challenges
Iram Iqbal, Fatima Saqib, Zobia Mubarak, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 16
Memantine: Updating a rare success story in pro-cognitive therapeutics
Parisa Karimi Tari, Chris G. Parsons, Graham L. Collingridge, et al.
Neuropharmacology (2023) Vol. 244, pp. 109737-109737
Open Access | Times Cited: 27
Recent advancement in therapeutic strategies for Alzheimer’s disease: Insights from clinical trials
Tanzeel Khan, Rashid Waseem, Mohammad Shahid, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102113-102113
Closed Access | Times Cited: 25
Navigating the dementia landscape: Biomarkers and emerging therapies
Shubhrat Maheshwari, Aditya Singh, Valeed Ahmad Ansari, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102193-102193
Closed Access | Times Cited: 14
Review on anti-alzheimer drug development: approaches, challenges and perspectives
Abdallah E. Abdallah
RSC Advances (2024) Vol. 14, Iss. 16, pp. 11057-11088
Open Access | Times Cited: 14
Effect of the ROCK inhibitor fasudil on the brain proteomic profile in the tau transgenic mouse model of Alzheimer's disease
Roberto Collu, Zheng Yin, Elisa Giunti, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 10
The 2023 yearbook of Neurorestoratology
Hongyun Huang, John R. Bach, Hari Shanker Sharma, et al.
Journal of Neurorestoratology (2024) Vol. 12, Iss. 3, pp. 100136-100136
Open Access | Times Cited: 9
Proposed mechanisms of tau: relationships to traumatic brain injury, Alzheimer’s disease, and epilepsy
Samantha P. Martin, Beth A. Leeman-Markowski
Frontiers in Neurology (2024) Vol. 14
Open Access | Times Cited: 8
Unveiling the safety profile of lecanemab: A comprehensive analysis of adverse events using FDA adverse event reporting system data
Wukun Ge, Y. Yan, Yaoyao Hu, et al.
Journal of Alzheimer s Disease (2025)
Open Access | Times Cited: 1
Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use
Michael Schöll, Agathe Vrillon, Takeshi Ikeuchi, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100056-100056
Open Access | Times Cited: 1
The potential roles of ATF family in the treatment of Alzheimer's disease
Ting Yang, Yuhong Zhang, Lixuan Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114544-114544
Open Access | Times Cited: 19
Lipid metabolism transcriptomics of murine microglia in Alzheimer’s disease and neuroinflammation
Daniel C. Shippy, Tyler K. Ulland
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 19
The association between triglyceride-glucose index and cognitive function in nondiabetic elderly: NHANES 2011–2014
Baojian Wei, Qianni Dong, Jinlong Ma, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Alzheimer’s Disease Treatment: The Search for a Breakthrough
Allison B. Reiss, Dalia Muhieddine, Berlin Jacob, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1084-1084
Open Access | Times Cited: 16
Clinical Meaningfulness in Alzheimer’s Disease Clinical Trials. A Report from the EU-US CTAD Task Force
Davide Angioni, J Cummings, C.J. Lansdall, et al.
The Journal of Prevention of Alzheimer s Disease (2024) Vol. 11, Iss. 5, pp. 1219-1227
Closed Access | Times Cited: 6
Under the umbrella of depression and Alzheimer’s disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?
Carla Fonseca, Miren Ettcheto, Joana Bicker, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 101998-101998
Open Access | Times Cited: 13
Synthesis and biological evaluation of novel pyrrolo[2,3-b]pyridine derivatives as potent GSK-3β inhibitors for treating Alzheimer's disease
Qingqing Xun, Jing Zhang, Yan-Peng Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117236-117236
Closed Access
Machine learning models for dementia screening to classify brain amyloid positivity on positron emission tomography using blood markers and demographic characteristics: a retrospective observational study
Noriyuki Kimura, Kotaro Sasaki, Teruaki Masuda, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access
Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
Rupal Dhariwal, Mukul Jain, Y. Mir, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Krüppel-like factor 9 alleviates Alzheimer’s disease via IDE-mediated Aβ degradation
Yue-yao Feng, Jianwei Hao, Yujie Zhang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Interventions of cognitive impairment in older adults: A comprehensive review
Shivani Chib, Kajal Sharma, Randhir Singh
Aging and Health Research (2025), pp. 100223-100223
Open Access
Advancements in Psychiatric Care: DSM-5-TR Revisions and Recent Psychopharmacological Developments
Elizabeth Hutson, Lyons T. Hardy, Erin Ellington, et al.
Journal of Psychosocial Nursing and Mental Health Services (2025), pp. 1-13
Closed Access
Page 1 - Next Page

Scroll to top